Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Apr;85(3):465-469.
doi: 10.1016/S0304-3959(99)00294-8.

Synergistic effect of cholecystokinin octapeptide and angiotensin II in reversal of morphine induced analgesia in rats

Nian-Lin Han  1 , Fei Luo, Zhu-Ping Bian, Ji-Sheng Han
Affiliations

Synergistic effect of cholecystokinin octapeptide and angiotensin II in reversal of morphine induced analgesia in rats

Nian-Lin Han et al. Pain. 2000 Apr.

Abstract

The aim of this paper is to study the synergistic anti-analgesic effect of angiotensin II (Ang II) plus cholecystokinin octapeptide (CCK-8). Our previous studies have shown that both CCK-8 and Ang II are potent anti-opioid substances. Intracerebroventricular (i.c.v.) injection of CCK-8 or Ang II dose-dependently antagonizes morphine-induced analgesia (MIA). In the present study, we observed the combined effect of CCK-8 and Ang II in antagonizing MIA. CCK-8 and Ang II were injected intracerebroventricularly to rats in various proportions and doses. The results were analyzed with isobolographic analysis. Combined injection of CCK-8 and Ang II in a ratio of 1 ng: 2.5 microg or 1 ng: 5 microg produced significantly greater effect in antagonizing MIA. The ED(50) of the two ratios are only 18.5% and 27.5%, respectively, of the theoretical dose of simple addition. We conclude that CCK-8 and Ang II used in such dose ratios may antagonize MIA synergistically.

PubMed Disclaimer

References

    1. Beinfeld MC. Cholecystokinin in the central nervous system: a mini review. Neuropeptides. 1983;3:411-427.
    1. Berenbaum MC. What is synergy? Pharmacol Rev. 1989;41:93-141.
    1. Faris PL, Komisaruk BR, Watkins LR, Mayer DJ. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 1983;219:310-312.
    1. Fields HL, Emson PC, Leigh BK, Gilbert RFT, Iversen LL. Multiple opiate receptor-sites on primary afferent fibers. Nature (Lond). 1980;284:351-353.
    1. Fujimoto JM, Arts KS, Rady JJ, Tseng LF. Spinal dynorphin A (1-17): possible mediator of antianalgesia action. Neuropharmacology. 1990;29:609-617.

Publication types